Novo Genomics of Saudi Arabia and Pakistan’s Precision Medicine Lab

Riyadh – September 27, 2025: Novo Genomics of Saudi Arabia and Pakistan’s Precision Medicine Lab have announced the launch of the Saudi-Pakistan Biotech Bridge Initiative, a strategic initiative aimed at strengthening scientific collaboration in genomics and precision medicine, and building shared genomic resources that serve regional health needs.

The initiative will focus on developing cross-border biobanks, conducting joint clinical trials, and applying AI-driven analytics to predict and prevent disease. It will also support academic exchange programs and host conferences to inspire the next generation of researchers and innovators.

Dr. Abdulelah Alhawsawi, CEO of Novo Genomics, said:
“This partnership represents a critical step toward building a regional genomics ecosystem that benefits both science and society.”

Dr. Faisal Khan, Director of Precision Medicine Lab, added:
“Our Lab is committed to impactful, world-class research. This collaboration opens new horizons for scientific partnership between Saudi Arabia and Pakistan.”

The Saudi-Pakistan Biotech Bridge is expected to become a new pillar of bilateral relations, complementing Vision 2030 and supporting knowledge-based economies in both nations.